New NIH Director Confronts Staff Concerns Amid Agency Turmoil
Summary:
NIH Director Bhattacharya faces tough questions at first town hall about layoffs, research policies, and political decisions while promising reforms despite skepticism from remaining staff.
First Prime Editing Gene Therapy Treats Rare Immune Disorder
Summary:
A teenager with chronic granulomatous disease received the first prime editing treatment, showing restored enzyme function in 67% of neutrophils with no serious side effects, though Prime Medicine seeks partners.
NSF Pauses 15% Overhead Cap as Universities Sue
Summary:
NSF suspends controversial 15% cap on university research overhead payments until June 13 court hearing, following similar freezes at NIH and DoE amid lawsuits from academic institutions.
Science Must Adapt to Federal Funding Cuts
Summary:
White House Science Advisor Kratsios tells researchers to prioritize as budgets shrink, claiming excessive spending yields diminishing returns and political biases undermine scientific integrity.
U.S. Drug Price Reform: HHS Matches Global Lowest Rates
Summary:
HHS unveils “most favored nation” drug pricing plan requiring manufacturers to match the lowest prices in OECD nations for branded drugs without generic competition.
